Coelho Rogerio Vivaldi

Insider Reports History

Entity
Individual
Location
225 Second Avenue, Waltham, MA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Coelho Rogerio Vivaldi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 14.4K $684K $47.49 Jun 7, 2024 Direct
Viatris Inc Director Restricted Stock Units 21.3K $221K $10.38 Jun 3, 2024 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 12.5K Jun 7, 2024 Direct
Sigilon Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 0 Aug 11, 2023 Direct
Sigilon Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 0 $0.75 Aug 11, 2023 Direct

Insider Reports Filed by Coelho Rogerio Vivaldi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
VTRS Viatris Inc Jun 3, 2024 1 $0 4 Jun 4, 2024 Director
VTRS Viatris Inc Jun 3, 2024 0 $0 3 Jun 4, 2024 Director
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 2 -$26.5K 4 Aug 11, 2023 PRESIDENT AND CEO, Director
SGTX Sigilon Therapeutics, Inc. Jul 21, 2023 2 $106K 4 Jul 24, 2023 PRESIDENT AND CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 8, 2023 1 $110K 4 Jun 9, 2023 Director
SGTX Sigilon Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 1, 2023 PRESIDENT AND CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
SGTX Sigilon Therapeutics, Inc. Feb 18, 2022 1 $340K 4 Feb 22, 2022 PRESIDENT AND CEO, Director
CRNX Crinetics Pharmaceuticals, Inc. Jan 3, 2022 1 $0 4/A Apr 4, 2022 Director
CRNX Crinetics Pharmaceuticals, Inc. Jan 3, 2022 0 $0 3 Jan 10, 2022 Director
SGTX Sigilon Therapeutics, Inc. Jan 3, 2022 1 $1.21M 4 Jan 4, 2022 PRESIDENT AND CEO, Director
SGTX Sigilon Therapeutics, Inc. Nov 4, 2021 1 $0 4 Nov 5, 2021 PRESIDENT AND CEO, Director